SugarVita: a Digital Board Game - Trial NCT06392178
Access comprehensive clinical trial information for NCT06392178 through Pure Global AI's free database. This phase not specified trial is sponsored by Maxima Medical Center and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 2. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Maxima Medical Center
Timeline & Enrollment
N/A
Apr 01, 2024
Jun 01, 2025
Primary Outcome
To assess the impact of SugarVita on self-management,To assess the impact of SugarVita on self-confidence,To assess the impact of SugarVita on diabetes related knowledge
Summary
The serious digital game, SugarVita, is a collaborative effort between the Máxima Medical
 Centre (MMC) and Eindhoven University of Technology (TUe), intending to enhance
 self-management for individuals with diabetes. As a mobile application available on
 smartphones and tablets, SugarVita emerged from cooperative design sessions involving
 patients diagnosed with diabetes. The average age of type 2 diabetes patients in the
 Netherlands exceeds 50 years. Following extensive discussions with these patients, the
 decision was made to model SugarVita after a digital board game, reminiscent of the classic
 board game 'ganzenbord' (Game of the Goose). In SugarVita, players experience a day in the
 life of an individual with diabetes, making choices regarding dietary habits, physical
 activity, and medication intake. Throughout this simulated day, the blood glucose level
 serves as a central theme. Players earn points by effectively managing their blood glucose
 levels. SugarVita can be played together with relatives or friends. The game aims to give
 people with diabetes more control over their chronic condition. Self-care is now seen as the
 primary approach to diabetes, which is a complex multi-faceted task where training and
 education are crucial. Importantly, SugarVita recognizes that a conventional 'dry'
 explanation may not resonate with everyone.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06392178
Device Trial